Stock listing

Anaptysbio, Inc.

Selected listing: ANAB · NASDAQ · USD · US

Anaptysbio, Inc. (NASDAQ:ANAB), Health Technology. Latest release Sep 21, 2026: AnaptysBio : Annual Transition Report (Form 10-KT).

ANAB:NASDAQUSDUSUpdated October 2, 2026

Ticker: NASDAQ:ANAB
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: NASDAQ
Currency: USD

About Anaptysbio, Inc.

Anaptysbio, Inc. is a publicly traded biotechnology company listed under the ticker ANAB. Anaptysbio focuses on developing innovative therapeutic solutions in the field of immunology.

Latest news from Anaptysbio, Inc.

AnaptysBio : Annual Transition Report (Form 10-KT)

September 21, 2026

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

September 1, 2026

Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update

May 12, 2026

Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors

May 11, 2026

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

May 4, 2026

All Anaptysbio, Inc. news →

Research Anaptysbio, Inc.

Anaptysbio, Inc. company profile

View the public company page for Anaptysbio, Inc. on 6ix.

Anaptysbio, Inc. news

Read company news and market updates connected to Anaptysbio, Inc..

Anaptysbio, Inc. investor events

Find investor webinars, events, and replay context for Anaptysbio, Inc..